VarmX and CSL form alliance for blood coagulation treatment development
As part of the collaboration, CSL will fully finance the Phase III EquilibriX-S trial of VMX-C001.
Drug Development
Kashiv signs deal with CRISTÁLIA for Xolair biosimilar in LATAM
GTCR to acquire generic drug maker Zentiva
Kriya gains $320m in Series D for gene therapy development
Sanofi’s Tzield gains approval in China for T1D management
Kytopen and BlueWhale Bio partner for cell therapy innovation
Health Canada approves Medison and Ipsen’s Bylvay to treat ALGS
Servier to acquire potential Fragile X syndrome treatment from Kaerus
